Levamlodipine Maleate 1.25 mg, 2.5 mg, 5 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 1.25 mg, 2.5 mg, 5 mg

Reference Brands: Conjupri (USA)

Category: Heart Disorder

Levamlodipine is the active S-enantiomer of amlodipine, a calcium channel blocker for high blood pressure and angina. Because it is the active half of the molecule, it works at half the amlodipine dose. It is approved in the US as Conjupri and widely used in India and China in 1.25 mg, 2.5 mg and 5 mg tablets. PharmaTradz sources it for importers, hospitals and tenders, and shares GMP certificates and CoA before you commit.

Product Description:

Levamlodipine is the pharmacologically active S-enantiomer of amlodipine and belongs to the dihydropyridine class of calcium channel blockers. It is primarily used for the treatment of hypertension and angina pectoris. By selectively blocking calcium channels in vascular smooth muscle, levamlodipine helps relax and widen blood vessels, which improves blood flow and reduces blood pressure. This mechanism also decreases the workload on the heart, making it beneficial in managing cardiovascular conditions.

Levamlodipine offers similar therapeutic benefits to amlodipine but at lower doses due to its active enantiomeric form, which may help reduce certain side effects associated with racemic amlodipine. The medication is commonly prescribed for patients who require long-term blood pressure control and prevention of angina episodes.

Levamlodipine received approval from the U.S. Food and Drug Administration in December 2019 and is marketed in the United States under the brand name Conjupri. With its effective antihypertensive and antianginal properties, levamlodipine has become an important therapeutic option in cardiovascular management when used under appropriate medical supervision.